Delivery Order SPE2DB20D1100-SPE2DB25FD9S5
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Methylphenidate transdermal patches (30 mg, 30-count) with a firm fixed price ceiling value of $1,549.23. This is a non-set-aside competitively awarded delivery order under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 11, 2025. The contract represents a child order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,052.12 to AmerisourceBergen Drug Corp for Methylphenidate 20 mg/9-hour patches (30 count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency awarded a $996.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 boxes containing 10 mg/9 hour patch doses of methylphenidate. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order was issued against an existing DLA contract vehicle and runs from June 28, 2023 through June 29, 2023. As a leading provider of pharmaceuticals and healthcare products, Amerisourcebergen will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,805.48. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) valued at $4,498.98. This competitive award (no set-aside used) is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- The Defense Logistics Agency Troop Support Medical awarded a $498,420 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 boxes containing 20mg methyl phenidate patches with a 9-hour delivery period. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a firm fixed price and period of performance from July 27, 2023 through July 28, 2023. No set aside designation or subcontractors were identified. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count) on August 28, 2025, with a ceiling value of $1,825.53. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is executed under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9S5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate 10 mg/9-hour patches (30-count units) with a ceiling value of $9,352.51. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and is scheduled for completion by August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive contract portfolio with the Defense Logistics Agency and military healthcare systems. The company's federal awards demonstrate capability in supplying a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively awarded with firm fixed pricing, reflecting its ability to meet federal procurement requirements. The DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, continuing AmerisourceBergen's role in supporting military healthcare procurement alongside other government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/11/25 |